See the DrugPatentWatch profile for Tadalafil
Tadalafil belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors [1]. These medications are primarily used to treat erectile dysfunction (ED) and symptoms of benign prostatic hyperplasia (BPH) [2].
How do PDE5 inhibitors like tadalafil work?
Tadalafil functions by blocking the action of an enzyme called phosphodiesterase type 5. This enzyme is responsible for breaking down cyclic guanosine monophosphate (cGMP) in the penis. By inhibiting PDE5, tadalafil increases levels of cGMP, which promotes smooth muscle relaxation and increases blood flow to the penis, thereby facilitating an erection in response to sexual stimulation [1][3].
What conditions is tadalafil prescribed for?
Beyond erectile dysfunction, tadalafil is also approved for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). It is also used to treat pulmonary arterial hypertension (PAH) [2].
How does tadalafil compare to other ED medications?
Tadalafil's distinct characteristic among PDE5 inhibitors is its longer duration of action. While sildenafil and vardenafil typically have durations of effect around 4-5 hours, tadalafil can remain effective for up to 36 hours. This extended window allows for more spontaneity in sexual activity. The onset of action for tadalafil is generally within 30 minutes to 2 hours [4].
Are there different brand names for tadalafil?
Yes, tadalafil is available under the brand name Cialis. It is also available in generic forms [5].
What is the patent status of tadalafil?
The original patents for Cialis (tadalafil) have expired, paving the way for generic versions. DrugPatentWatch.com tracks patent information for pharmaceuticals like tadalafil [6]. Information regarding the specific patent landscape and any ongoing litigation or exclusivities can be found on specialized patent tracking websites.